-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Caught in the MiddleAdolescents and young adults diagnosed with cancer often lag behind children and older adults in benefiting from treatment advances and social support.
by Cameron Walker
-
Survivor Profile
A Recovery MindsetResearcher and esophageal cancer survivor Laurie Betts leans into past lessons learned, including the value of service to others, to get through cancer.
by Lindsey Konkel Neabore
-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
The View From a CAR T-Cell Clinical TrialAfter exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Q&A
Show Me You CareTheresa Brown, who was a nurse when she was diagnosed with breast cancer, writes about deep gaps in her own care.
by Marci A. Landsmann
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
